Effect of captopril treatment on recuperation from ischemia/reperfusion- induced acute renal injury

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 136-145

  Efrati, Shai ^a   Berman, Sylvia ^a   Hamad, Ramzia Abu ^a   Siman Tov, Yariv ^a   Ilgiyaev, Eduard ^a   Maslyakov, Ilia ^a   Weissgarten, Joshua ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ACE inhibition; AKI; angiotensin II; hypoxia; inflammation

Indexed keywords

8 ISOPROSTANE; ANGIOTENSIN II; CAPTOPRIL; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; ENZYME INHIBITION; HISTOPATHOLOGY; HORMONE SYNTHESIS; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; TISSUE STRUCTURE;

ACUTE KIDNEY INJURY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANOXIA; APOPTOSIS; BLOOD PRESSURE DETERMINATION; CAPTOPRIL; CYTOKINES; INFLAMMATION; KIDNEY FUNCTION TESTS; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; REPERFUSION INJURY;

EID: 84856684672     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr256     Document Type: Article

References (49)

1. Schiffl H, Lang S. Acute kidney injury as a risk and progression factor for chronic kidney injury. Minerva Urol Nefrol 2009; 61: 159-169
2. Basile C. The long-term prognosis of acute kidney injury: acute renal failure as a cause of chronic kidney disease. J Nephrol 2008; 21: 657-662
3. Goldberg R, Dennen P. Long-term outcomes of acute kidney injury. Adv Chronic Kidney Dis 2008; 15: 297-307 (Pubitemid 351822598)
4. Venkatachalam MA, Griffin KA, Lan R et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 2010; 15: 1078-1094
5. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520 (Pubitemid 43841396)
6. Yang CC, Ma MC, Chien CT et al. Hypoxic preconditioning attenuates lipopolysaccharide-induced oxidative stress in rat kidneys. J Physiol 2007; 582: 407-419
7. Persson PB. The magic mountain or death in Venice: chronic hypoxia may alleviate oxidative stress in the kidney. J Physiol 2007; 582: 1 (Pubitemid 46993550)
8. Karaman A, Turkmen E, Gursul C et al. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide. Int J Urol 2006; 13: 1434-1441 (Pubitemid 44657055)
9. Thurman JM. Triggers of inflammation after renal ischemia/reperfu-sion. Clin Immunol 2007; 123: 7-13
10. Krishan P, Sharma A, Singh M. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats. Pharmacol Res 1998; 37: 23-29 (Pubitemid 28068677)
11. Altunoluk B, Soylemez H, Oguz F et al. An angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci 2006; 36: 326-332 (Pubitemid 44320428)
12. Efrati S, Berman S, Goldfinger N et al. Enhanced angiotensin II production by renal mesangium is responsible for apoptosis/prolifer-ation of endothelial and epithelial cells in a model of malignant hypertension. J Hypertens 2007; 25: 1041-1052 (Pubitemid 46573124)
13. Rodriguez-Lopez AM, Flores O, Arevalo MA et al. Glomerular cell proliferation and apoptosis in uninephrectomized spontaneously hypertensive rats. Kidney Int Suppl 1998; 68: S36-S40 (Pubitemid 28531773)
14. Wolf G, Neilson EG. Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 1990; 259: F768-F777 (Pubitemid 20385693)
15. Lodha S, Dani D, Mehta R et al. Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med 2002; 8: 830-840 (Pubitemid 36223136)
16. Berl T. Review: renal protection by inhibition of the renin-angioten-sin-aldosterone system. J Renin Angiotensin Aldosterone Syst 2009; 10: 1-8
17. Remuzzi G, Perico N, Macia M et al. The role of renin-angiotensin- aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005; (99): S57-S65
18. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: renopro-tective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-615 (Pubitemid 34407045)
19. Bedogna V, Valvo E, Casagrande P et al. Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 1990; 38: 101-107 (Pubitemid 20209438)
20. Mii A, Shimizu A, Masuda Y et al. Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression. Lab Invest 2009; 89: 164-177
21. Fouad AA, Qureshi HA, Al-Sultan AI et al. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology 2010; 85: 158-167
22. Sterzel RB, Schulze-Lohoff E, Weber M et al. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix. J Am Soc Nephrol 1992; 2: S126-S131
23. Todorovic V, Jurukovski V, Chen Y et al. Latent TGF-beta binding proteins. Int J Biochem Cell Biol 2005; 37: 38-41
24. Chana RS, Martin J, Rahman EU et al. Monocyte adhesion to me-sangial matrix modulates cytokine and metalloproteinase production. Kidney Int 2003; 63: 889-898 (Pubitemid 36315566)
25. Wakefield LM, Winokur TS, Hollands RS et al. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990; 86: 1976-1984
26. Renzoni EA, Abraham DJ, Howat S et al. Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts. Respir Res 2004; 5: 24
27. Martin MM, Buckenberger JA, Jiang J et al. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p.38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol 2007; 293: L790-L799 (Pubitemid 47358842)
28. Zager RA, Johnson AC, Lund S. Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury. Am J Physiol Renal Physiol 2009; 297: F961-F970
29. Grigoryev DN, Liu M, Hassoun HT et al. The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Neph-rol 2008; 19: 547-558 (Pubitemid 351355398)
30. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56: 1-26 (Pubitemid 24242221)
31. Kitching AR, Katerelos M, Mudge SJ et al. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol 2002; 128: 36-43 (Pubitemid 34451177)
32. Fouqueray B, Boutard V, Philippe C et al. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysacchar-ide. Am J Pathol 1995; 147: 176-182
33. Daemen MA, van de Ven MW, Heineman E et al. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 1999; 67: 792-800 (Pubitemid 29169122)
34. Kitching AR, Tipping PG, Huang XR et al. Interleukin-4 and inter-leukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 1997; 52: 52-59 (Pubitemid 27321814)
35. Kalechman Y, Gafter U, Weinstein T et al. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J Biol Chem 2004; 279: 24724-24732 (Pubitemid 38725340)
36. Morrissey JJ, Ishidoya S, McCracken R et al. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 1996; 7: 2202-2212 (Pubitemid 27468250)
37. Brezis M, Rosen S, Silva P et al. Renal ischemia: a new perspective. Kidney Int 1984; 26: 375-383 (Pubitemid 15224578)
38. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem Lab Med 1999; 37: 389-395 (Pubitemid 29218957)
39. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-1122 (Pubitemid 39121017)
40. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38 (Suppl 1): S20-S27 (Pubitemid 23092541)
41. Grubb AO. Cystatin C-properties and use as diagnostic marker. Adv Clin Chem 2000; 35: 63-99
42. Schurek HJ, Jost U, Baumgartl H et al. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol 1990; 259: F910-F915
43. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25
44. Morrell NW, Atochina EN, Morris KG et al. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 1995; 96: 1823-1833
45. Lam SY, Leung PS. A locally generated angiotensin system in rat carotid body. Regul Pept 2002; 107: 97-103 (Pubitemid 34876450)
46. Lam SY, Leung PS. Chronic hypoxia activates a local angiotensin- generating system in rat carotid body. Mol Cell Endocrinol 2003; 203: 147-153 (Pubitemid 36627595)
47. Leung PS, Lam SY, Fung ML. Chronic hypoxia upregulates the expression and function of AT(1) receptor in rat carotid body. J Endo-crinol 2000; 167: 517-524 (Pubitemid 32047559)
48. Thorsson O, Bjuvang A, Granerus G. Advantages of standardized criteria for the interpretation of angiotensin-converting enzyme inhibition renography. Nucl Med Commun 2009; 30: 449-454
49. Palm F, Connors SG, Mendonca M et al. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early Goldblatt hypertensive rats. Hypertension 2008; 51: 345-351 (Pubitemid 351159949)